Prospecção farmacológica da ação analgésica do canabidiol através de docking molecular: interações com o canal de sódio dependente de voltagem Nav1.7

Autores

DOI:

https://doi.org/10.33448/rsd-v12i3.40292

Palavras-chave:

Canabidiol; Analgésico; Modelagem de drogas; Canal de sódio dependente de voltagem Nav1.7.

Resumo

Objetivo: analisar a interação do canabidiol (CBD) com Nav1.7 e comparar com a carbamazepina (CBZ) através de docking molecular. Metodologia: trata-se de uma pesquisa quantitativa e experimental, do tipo in silico, que utilizou como substâncias testes, o CBD (CID: 644019) e a carbamazepina (CID: 2554, bloqueador controle), anticonvulsivante padrão utilizado na dor crônica, sobre o canal Nav1.7 (PDB: 6N4I), como proteína alvo. Os experimentos de docking molecular foram obtidos usando o portal online Dockthor®, analisados e visualizados pelo UCSF Chimera®. Os resultados das simulações do CBD e da CBZ foram estabelecidos em ordem de maior afinidade com a proteína canal. As afinidades foram comparadas utilizando teste “t” de Student no programa GraphPad Prism®, onde valores de p < 0,05 foram considerados significantes. Resultados: foram realizadas 1.000,000 avaliações das possíveis interações do CDB e CBZ no Nav1.7, destas as três melhores, com menor energia de ligação (kcal/mol) ou melhor afinidade, foram selecionadas. O CBD e CBZ apresentaram afinidade de - 8,61 ± 0,008 e - 8,47 ± 0,27 kcal/mol, respectivamente. Comparando-se esses valores, notou-se que não houve diferença estatística significante (p = 0,31), o que se reflete posicionamentos similares de cada um no canal e também possível potência terapêutica. O CBD fez uma ligação de hidrogênio com o resíduo THR180 com uma distância de 1,86 Å. Conclusões: o canabidiol se liga ao Nav1.7, sendo capaz de bloqueá-lo. Estes dados fundamentam o uso clínico do canabidiol como analgésico pela via inibitória neuronal.

Biografia do Autor

Gidelson José da Silva Júnior, Faculdade de Medicina de Olinda

Student at graduate Medicine

Gisele Evelin de Jesus Arruda, Faculdade de Medicina de Olinda

Student at graduate of Medicine.

Nayara Barbosa Dantas Lira, Faculdade de Medicina de Olinda

Student at graduate of Medicine.

Neuton Barbosa Dantas Lira, Faculdade de Medicina de Olinda

Student at graduate of Medicine.

Alessandra Emertice de Almeida Costa, Universidade Estadual de Campinas

Student of Post-graduate.

Cintia Yoko Morioka, Advantage Health

Professor at colaborating.

Referências

Bankar, G., Goodchild, S. J., et al. (2018). Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain. Cell Reports, 24(12), 3133–3145. https://doi.org/10.1016/j.celrep.2018.08.063

Carlini, E. A. (2006). A história da maconha no Brasil. Jornal Brasileiro de Psiquiatria, 55(4), 314-317.

Casey, S. L., Atwal, N., & Vaughan, C. W. (2017). Cannabis constituent synergy in a mouse neuropathic pain model. Pain, 158(12), 2452–2460. https://doi.org/10.1097/j.pain.0000000000001051

Catterall, W. A. (2012). Voltage-gated sodium channels at 60: structure, function and pathophysiology. The Journal of Physiology, 590(11), 2577-89. https://doi.org/10.1113/jphysiol.2011.224204

De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011). Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology, 163(7), 1479–1494. https://doi.org/10.1111/j.1476-5381.2010.01166.x

Devinsky, O., Cross, J. H., & Wright, S. (2017a). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. The New England Journal of Medicine, 377(7), 699–700. https://doi.org/10.1056/NEJMc1708349

Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017b). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. The New England Journal of Medicine, 376(21), 2011–2020. https://doi.org/10.1056/NEJMoa1611618

Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., Wong, M., Tilton, N., Bruno, P., Bluvstein, J., Hedlund, J., Kamens, R., Maclean, J., Nangia, S., Singhal, N. S., Wilson, C. A., … Cilio, M. R. (2016). Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. The Lancet. Neurology, 15(3), 270–278. https://doi.org/10.1016/S1474-4422(15)00379-8

Dib-Hajj, S. D., Cummins, T. R., Black, J. A., & Waxman, S. G. (2007). From genes to pain: Na v 1.7 and human pain disorders. Trends in Neurosciences, 30(11), 555–563. https://doi.org/10.1016/j.tins.2007.08.004

Dib-Hajj, S. D., Cummins, T. R., Black, J. A., & Waxman, S. G. (2010). Sodium channels in normal and pathological pain. Annual Review of Neuroscience, 33, 325–347. https://doi.org/10.1146/annurev-neuro-060909-153234

Dravet, C. (2011). The core Dravet syndrome phenotype. Epilepsia 52:3–9.

Du, G., Qu, X., Hu, J., Zhang, Y., & Cai, Y. (2022). Identification of Taohong Siwu Decoction in Treating Chronic Glomerulonephritis Using Network Pharmacology and Molecular Docking. Natural Product Communications, 17(11), 1-12.

Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011). The cognitive impact of antiepileptic drugs. Therapeutic Advances in Neurological Disorders, 4(6), 385–407. https://doi.org/10.1177/1756285611417920

Emery, E. C., Luiz, A. P., & Wood, J. N. (2016). Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opinion on Therapeutic targets, 20(8), 975–983. https://doi.org/10.1517/14728222.2016.1162295

Forsythe, I., Butler, R., Berg, I., & McGuire, R. (1991). Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Developmental Medicine and Child Neurology, 33(6), 524–534. https://doi.org/10.1111/j.1469-8749.1991.tb14917.x

Ghovanloo, M. R., Choudhury, K., Bandaru, T. S., Fouda, M. A., Rayani, K., Rusinova, R., Phaterpekar, T., Nelkenbrecher, K., Watkins, A. R., Poburko, D., Thewalt, J., Andersen, O. S., Delemotte, L., Goodchild, S. J., & Ruben, P. C. (2021). Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity. The Journal of General Physiology, 153(5), e202012701. https://doi.org/10.1085/jgp.202012701

Ghovanloo, M. R., Shuart, N. G., Mezeyova, J., Dean, R. A., Ruben, P. C., & Goodchild, S. J. (2018). Inhibitory effects of cannabidiol on voltage-dependent sodium currents. The Journal of Biological Chemistry, 293(43), 16546–16558. https://doi.org/10.1074/jbc.RA118.004929

Ghovanloo, M. R., & Ruben, P. C. (2020). Say Cheese: Structure of the Cardiac Electrical Engine Is Captured. Trends in Biochemical Sciences, 45(5), 369–371. https://doi.org/10.1016/j.tibs.2020.02.003

Hill, K. P. (2015). Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA, 313(24), 2474–2483. https://doi.org/10.1001/jama.2015.6199

Hudson, R., & Puvanenthirarajah, N. (2018). Cannabis for pain management: Pariah or panacea? University of Western Ontario Medical Journal, 87(1), 58-61.

Kang, H. C., Eun, B. L., Wu Lee, C., Ku Moon, H., Kim, J. S., Wook Kim, D., Soo Lee, J., Young Chae, K., Ho Cha, B., Sook Suh, E., Chae Park, J., Lim, K., Hye Ha, E., Ho Song, D., Dong Kim, H., & Korean Pediatric Topiramate Study Group (2007). The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia, 48(9), 1716–1723. https://doi.org/10.1111/j.1528-1167.2007.01160.x

Magalhães, C. S., et al. (2014). A dynamic niching genetic algorithm strategy for docking of highly flexible ligands. Information Sciences, 289;206–24.

Patel, R. R., Barbosa, C., Brustovetsky, T., Brustovetsky, N., & Cummins, T. R. (2016). Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. Brain, 139(8), 2164–81.

Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Santa Maria, RS: UFSM, NTE.

http://repositorio.ufsm.br/handle/1/15824

PubChem. National Center for Biotechnology Information. Disponível em: https://pubchem.ncbi.nlm.nih.gov

Romero-Sandoval, E. A., Fincham, J. E., Kolano, A. L., Sharpe, B. N., & Alvarado-Vázquez, P. A. (2018). Cannabis for chronic pain: challenges and considerations. Pharmacotherapy 38:651–662.

Ross, H. R., Napier, I., & Connor, M. (2008). Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. The Journal of Biological Chemistry, 283(23), 16124–16134. https://doi.org/10.1074/jbc.M707104200

Sait, L. G., Sula, A., Ghovanloo, M. R., Hollingworth, D., Ruben, P. C., & Wallace, B. A. (2020). Cannabidiol interactions with voltage-gated sodium channels. eLife, 9, e58593. https://doi.org/10.7554/eLife.58593

Shehata, G. A., Bateh, A.el-A., Hamed, S. A., Rageh, T. A., & Elsorogy, Y. B. (2009). Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy. Neuropsychiatric Disease and Treatment, 5, 527–533. https://doi.org/10.2147/ndt.s5903

Skaper, S. D., & Di Marzo, V. (2012). Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 367(1607), 3193–3200. https://doi.org/10.1098/rstb.2012.0313

Teixeira, L. R., Silva Júnior, J. J., Vieira, P. H. S., Canto, M. V. G., Figueirêdo, A. G. M., & Silva J. L. V. (2021). Tamoxifen inhibits the anion channel induced by Staphylococcus aureus α-hemolysin: electrophysiological and docking analysis. RSD [Internet], 10(2), e13010212326.

Vitale, R. M., Iannotti, F. A., & Amodeo, P. (2021). The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets. International Journal of Molecular Sciences, 22(9), 4876. https://doi.org/10.3390/ijms22094876

Wesnes, K. A., Edgar, C., Dean, A. D., & Wroe, S. J. (2009). The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy & Behavior: E&B, 14(3), 522-528. https://doi.org/10.1016/j.yebeh.2008.11.012

Witt, J. A., & Helmstaedter, C. (2013). Monitoring the cognitive effects of antiepileptic pharmacotherapy--approaching the individual patient. Epilepsy & behavior: E&B, 26(3), 450–456. https://doi.org/10.1016/j.yebeh.2012.09.015

Downloads

Publicado

18/02/2023

Como Citar

SILVA JÚNIOR, G. J. da; ARRUDA, G. E. de J.; LIRA, N. B. D.; LIRA, N. B. D.; COSTA, A. E. de A.; MORIOKA, C. Y.; SILVA, J. L. V. da. Prospecção farmacológica da ação analgésica do canabidiol através de docking molecular: interações com o canal de sódio dependente de voltagem Nav1.7. Research, Society and Development, [S. l.], v. 12, n. 3, p. e30340292, 2023. DOI: 10.33448/rsd-v12i3.40292. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/40292. Acesso em: 22 dez. 2024.

Edição

Seção

Ciências da Saúde